Novartis acquires Mariana Oncology, strengthening RLT pipeline
Novartis has entered into an agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts focused on developing novel radioligand therapies (RLTs) to treat cancers with high unmet patient need. 👉 Transaction reinforces company’s strategic focus on developing next-generation treatment options for patients living with cancer.…
